Amends GS 90-85.3A to allow a pharmacist to order and perform a CLIA-waived test to: (1) assist with clinical decision making related to the use and monitoring of medications; and (2) treat influenza, pharyngitis caused by streptococcus, and other health conditions screened by using a CLIA-waived test. Defines CLIA-waived test as a lab test approved by the FDA and determined by the Centers for Medicare and Medicaid Services to qualify for a waiver under the federal Clinical Laboratory Improvement Amendments of 1988 and safe for use in non-laboratory settings. Effective October 1, 2022.
Bill Summaries: S885 PHARMACISTS REIMBURSEMENT/TEST/TREAT.
Bill S 885 (2021-2022)Summary date: May 27 2022 - View Summary